Bio-Rad Laboratories, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Bio-Rad Laboratories, Inc. filed 2 open-market sales worth $349,886 and 0 open-market purchases, on Form 4 with the SEC. The latest: Engelhardt Eva Anette, EVP, President, CDG, sold 550 shares at $246.54 on 11 May 2026, filed 13 May 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 11 May 2026 | Engelhardt Eva Anette | EVP, President, CDG | Sale | 550 | $246.54 | $135,597 | Form 4 |
| 6 November 2025 | Barry James | EVP, President, LSG | Sale | 700 | $306.18 | $214,289 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Bio-Rad Laboratories, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.